Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Mainz Biomed (MYNZ) stocks

Learn how to easily invest in Mainz Biomed stocks.

Mainz Biomed is a diagnostics & research business based in the US. Mainz Biomed stocks (MYNZ.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $10.56 – an increase of 4.39% over the previous week. Mainz Biomed employs 58 staff and has a trailing 12-month revenue of around $529,877.

How to buy Mainz Biomed stock

  1. Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – MYNZ. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Promoted for Beginners


National Bank Direct Brokerage

  • Commission-free trading
  • Several account types available
  • Access to array of research tools

Promoted for Low Fees

CIBC Investor's Edge

  • Easy to use platform
  • Low fees
  • Student and young investor discounts

Best for Lowest Commissions

Finder Award

Interactive Brokers

  • Access to international stock exchanges
  • Low margin rates
  • Powerful research tools

Mainz Biomed stock price (NASDAQ:MYNZ)

Use our graph to track the performance of MYNZ stocks over time.

Mainz Biomed shares at a glance

Information last updated 2023-05-20.
Latest market close$5.23
52-week range$3.18 - $12.40
50-day moving average $5.51
200-day moving average $7.11
Wall St. target price$11.00
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-1.75

Buy Mainz Biomed stocks from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Note: The dollar amounts in the table below are in Canadian dollars.

1 - 5 of 5
Name Product Finder Rating Available Asset Types Stock Trading Fee Account Fee Signup Offer Table description
National Bank Direct Brokerage
Finder Rating:
4.2 / 5
Stocks, Bonds, Options, Mutual Funds, GICs
$0 if conditions met, or $100
Get $0 commission on all transactions with promo code: finder
CIBC Investor's Edge
Finder Rating:
3.8 / 5
Stocks, Bonds, Options, Mutual Funds, ETFs
$0 if conditions met, or $100
An easy-to-use platform with access to a variety of tools to help you trade with confidence.
Interactive Brokers
Finder Rating:
4.3 / 5
Stocks, Bonds, Options, ETFs, Currencies, Futures
min $1.00, max 0.5%
Winner for Best Overall Broker in the Finder Stock Trading Platform Awards.
Finder Rating:
4.3 / 5
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
$4.95 - $9.95
Get $50 in free trades when you fund your account with a minimum of $1,000.
Opt for self-directed investing and save on fees or get a pre-built portfolio to take out some of the guesswork.
Qtrade Direct Investing
Finder Rating:
3.7 / 5
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Get up to $150 sign-up bonus. Use promo code BONUS150. Conditions apply. Ends June 30, 2023.
Low trading commissions and an easy-to-use platform with access to powerful tools and a wide selection of investment options.

Is it a good time to buy Mainz Biomed stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Mainz Biomed price performance over time

Historical closes compared with the close of $5.23 from 2023-05-26

1 week (2023-05-19) 4.39%
1 month (2023-04-28) 31.74%
3 months (2023-02-28) -26.23%
6 months (2022-11-28) -41.89%
1 year (2022-05-27) -55.90%
2 years (2021-05-24) N/A
3 years (2020-05-24) N/A
5 years (2018-05-24) N/A
[/expander_content] [/expander]

Mainz Biomed financials

Revenue TTM $529,877
Gross profit TTM $177,622
Return on assets TTM -109.43%
Return on equity TTM -257.98%
Profit margin 0%
Book value $0.96
Market capitalisation $74.3 million

TTM: trailing 12 months

Mainz Biomed share dividends

We're not expecting Mainz Biomed to pay a dividend over the next 12 months.

Mainz Biomed overview

Mainz Biomed N. V. , a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics. It offers ColoAlert, a colorectal cancer screening stool-based deoxyribonucleic acid test; and PancAlert, a product candidate for a pancreatic cancer screening test. The company has a research collaboration with Microba Life Sciences to discover and develop novel therapeutics for major diseases. The company was founded in 2008 and is based in Mainz, Germany. .

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Ask an Expert

You must be logged in to post a comment.

Go to site